Cholesterol October 28, 2015 6 lifestyle factors may predict young women’s heart disease risk, study says A 20-year study of nearly 70,000 women suggests that lifestyle factors impact heart attack risk in early adulthood.
Cholesterol October 28, 2015 Statins can be stopped toward the end of life Taking people off cholesterol-lowering medications near the end of life is safe and may actually be beneficial, according to a new study.
Medications October 28, 2015 New heart drug guidelines efficient and cost effective New guidelines for prescribing cholesterol-lowering medications are efficient and cost-effective, according to two new studies.
DIGESTIVE HEALTH October 28, 2015 Gut bacteria from high-fat animal products may cause kidney failure, study finds A digestion byproduct derived from high-fat animal products and previously found to increase the risk of heart disease has now also been linked to chronic kidney disease (CKD), according to a study published Thursday in the journal Circulation.
Diabetes Type 2 October 28, 2015 Early diabetes detection tied to fewer heart problems Earlier screening, diagnosis and treatment of type 2 diabetes may decrease the risk of cardiovascular problems, hint results from a computer model.
Genetics October 28, 2015 Gene mutation discovery boosts interest in heart drug Scientists have discovered gene mutations that give people naturally lower cholesterol levels and cut their risk of heart disease in half.
Medications October 28, 2015 Cholesterol drugs may aid critically ill patients For critically ill hospital patients, continued use of statins may help prevent confusion and disorientation.
Cholesterol October 28, 2015 Women more likely than men to have anxiety, depression after heart attack Heart attacks can impact women’s mental health more severely than men’s, suggests a new study from Lithuania.
Men's Health October 28, 2015 CDC study finds trans fats hidden in foods claiming zero on label A new study suggests Americans may be consuming dangerous amounts of trans fats and not even know it.
Cholesterol October 28, 2015 New cholesterol lowering drug much more expensive than statins A new cholesterol lowering drug called Praluent was recently approved by the U.S. Food and Drug Administration and introduced to the market. Praluent is said to be a better alternative to statins, but comes at a much higher price.
Medications October 28, 2015 Nonprofit finds new cholesterol drugs far too costly An independent nonprofit that evaluates clinical and cost effectiveness of new medicines said announced prices for a just-approved class of potent cholesterol lowering drugs were far too high, according to a draft report released on Tuesday.
